Effects of price cap regulation on pharmaceutical supply chain under the zero markup drug policy

Extended Producer Responsibility for Pharmaceuticals

(2021) Işıl Alev et al.   M&SOM-Manufacturing & Service Operations Management

Effects of different mark-up drug policies on drug-related expenditures in tertiary public hospitals: an interrupted time series study in Shanghai, China, 2015-2018

(2020) Xianji Wang et al.   BioScience Trends

Evaluating the effects of quality regulations on the pharmaceutical supply chain

(2020) Xu Chen et al.   INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS

A supply chain coordination mechanism for common items subject to failure in the electronics, defense, and medical industries

(2018) Mikhail M. Sher et al.   INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS

Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study

(2018) Yunzhen He et al.   PLoS One

Supply chain coordination under a revenue-sharing contract with corporate social responsibility and partial demand information

(2018) Syed Asif Raza   INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS

Reputational concerns with altruistic providers

(2017) Pau Olivella et al.   JOURNAL OF HEALTH ECONOMICS

Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts

(2016) Jia Hu et al.   HEALTH POLICY

Two-echelon pharmaceutical reverse supply chain coordination with customers incentives

(2016) Dua Weraikat et al.   INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS

Three-echelon supply chain coordination considering duopolistic retailers with perfect quality products

(2016) Nikunja Mohan Modak et al.   INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS

PBM Competition in Pharmaceutical Supply Chain: Formulary Design and Drug Pricing

(2015) Panos Kouvelis et al.   M&SOM-Manufacturing & Service Operations Management

Health system reform in rural China: Voices of healthworkers and service-users

(2014) Xu Dong Zhou et al.   SOCIAL SCIENCE & MEDICINE

The doctor–patient relationship, defensive medicine and overprescription in Chinese public hospitals: Evidence from a cross-sectional survey in Shenzhen city

(2014) Alex Jingwei He   SOCIAL SCIENCE & MEDICINE

Does the U.S. health care sector suffer from Baumol's cost disease? Evidence from the 50 states

(2013) Laurie J. Bates et al.   JOURNAL OF HEALTH ECONOMICS

Profit or patients’ health benefit? Exploring the heterogeneity in physician altruism

(2013) Geir Godager et al.   JOURNAL OF HEALTH ECONOMICS

Behaviour analysis of patients who purchase medicines on the internet: can hospital pharmacists facilitate online medication safety?

(2012) Andras Fittler et al.   European Journal of Hospital Pharmacy-Science and Practice

Optimal Design of a Pharmaceutical Price-Volume Agreement Under Asymmetric Information About Expected Market Size

(2011) Hui Zhang et al.   PRODUCTION AND OPERATIONS MANAGEMENT

Pharmaceutical supply chain in China: Current issues and implications for health system reform

(2010) Xuan Yu et al.   HEALTH POLICY